Appeal 2007-4193 Application 10/367,432 considered unexpected in view of the prior art by one of ordinary skill in this art. See, e.g., In re Geisler, 116 F.3d 1465, 1470, 43 USPQ2d 1362, 1365- 366 (Fed. Cir. 1997); In re Merck, 800 F.2d 1091, 1099, 231 USPQ 375, 381 (Fed. Cir. 1986); In re Longi, 759 F.2d 887, 897, 225 USPQ 645, 651-52 (Fed. Cir. 1985); In re Lindner, 457 F.2d 506, 508, 173 USPQ 356, 358 (CCPA 1972); In re Klosak, 455 F.2d 1077, 1080, 173 USPQ 14, 16 (CCPA 1972); In re D’Ancicco, 439 F.2d 1244, 1248, 169 USPQ 303, 306 (1971). On this record, Appellants have not carried this burden. We find the differences in preparation of the corrosion inhibitors and in the amounts and kind of ingredients between the compared Corrosion Inhibitors, the Samples containing the Corrosion Inhibitors, and the differences in the evaluation tests evince a number of unfixed variables which have not been explained. See, e.g., In re Dunn, 349 F.2d 433, 439, 146 USPQ 479, 483 (CCPA 1965) (“[W]e do not feel it an unreasonable burden on appellants to require comparative examples relied on for non- obviousness to be truly comparative. The cause and effect sought to be proven is lost here in the welter of unfixed variables.”). Indeed, in no comparison is the sole difference the average molecular weight of the polyisobutenyl group on the succinimide moiety and, in this respect, the differences in the polyamine linkage between the succinimide moieties in the respective Corrosion Inhibitors would reasonably be expected to affect the results obtained. See, e.g., In re Heyna, 360 F.2d 222, 228, 149 USPQ 692, 697 (CCPA 1966) (citing Dunn, 349 F.2d at 439, 146 USPQ at 483). Furthermore, Appellants’ only statement on the record with respect to the results obtained is that “better” results are achieved by the claimed 11Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next
Last modified: September 9, 2013